Frost Ronald 4

4 · MERIT MEDICAL SYSTEMS INC · Filed Mar 16, 2021

Form 4

Period: 2021-03-12

Chief Operating Officer

Transactions

Sale
Common Stock, No Par Value
2021-03-12$59.58/sh−25,000$1,489,500→ 7,343 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2021-03-12−25,000→ 0 total
Exercise: $12.06From: 2015-10-04Exp: 2021-10-04→ Common Stock (25,000 underlying)
Exercise/Conversion
Common Stock, No Par Value
2021-03-12$12.06/sh+25,000$301,500→ 32,343 total

Holdings

Common Stock, No Par Value
(indirect: By 401(k))
16,283.343
Non-qualified stock options (right to buy)
Exercise: $55.73From: 2020-03-01Exp: 2026-03-01→ Common Stock (30,000 underlying)
30,000
Non-qualified stock options (right to buy)
Exercise: $37.71From: 2021-02-26Exp: 2027-02-26→ Common Stock (16,722 underlying)
16,722
Non-qualified stock options (right to buy)
Exercise: $16.05From: 2017-01-28Exp: 2023-01-28→ Common stock (20,000 underlying)
20,000
Non-qualified stock options (right to buy)
Exercise: $44.80From: 2019-03-02Exp: 2025-03-02→ Common Stock (40,000 underlying)
40,000
Non-qualified stock options (right to buy)
Exercise: $17.27From: 2016-02-13Exp: 2022-02-13→ Common Stock (20,000 underlying)
20,000
Non-qualified stock options (right to buy)
Exercise: $28.20From: 2018-04-14Exp: 2024-04-14→ Common Stock (50,000 underlying)
50,000

Footnotes (9)

[F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.93 to $59.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F2]Represents plan holdings as of 02/26/2021.
[F3]Become exercisable in equal annual installments of 20% commencing 10/04/2015.
[F4]Become exercisable in equal annual installments of 20% commencing 02/13/2016.
[F5]Become exercisable in equal annual installments of 20% commencing 01/28/2017.
[F6]Become exercisable in equal annual installments of 20% commencing 04/14/2018.
[F7]Become exercisable in equal annual installments of 20% commencing 03/02/2019.
[F8]Become exercisable in equal annual installments of 20% commencing 03/01/2020.
[F9]Become exercisable in equal annual installments of 25% commencing 02/26/2021.

Documents

1 file